Ponoi II Management, LLC
Follow13F filer, CIK 1746488, San Francisco, CA
Ponoi II Management, LLC reported $36,802,000 across 4 holdings for the quarter ended 2022-06-30, in a 13F-HR filed 2022-08-12.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-22-008873
- Period
- 2022-06-30
- Reported value
- $36.8M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q2 2022
Share positions as resolved from 13F-HR 0000950123-22-008873, largest first. % of portfolio is the value over $36,802,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC | 1,298,908 | $16.7M | 45.25% | 0 | |||
| RVMDREVOLUTION MEDICINES INC | 685,011 | $13.4M | 36.28% | 0 | Timeline | ||
| NRIXNURIX THERAPEUTICS INC | 327,123 | $4.14M | 11.26% | 0 | Timeline | ||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 145,401 | $2.65M | 7.21% | 0 |
How Q2 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-22-008873 | base | 2022-08-12 | acceptance time not in the bulk data set |